{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:58:33Z","timestamp":1790488713679,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MIVS-ACT","award":["15SANIN211"],"award-info":[{"award-number":["15SANIN211"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cambodia is the epicentre of resistance emergence for virtually all antimalarial drugs. Selection and spread of parasites resistant to artemisinin-based combination therapy (ACT) is a major threat for malaria elimination, hence the need to renew the pool of effective treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether ACT resistance haplotypes could have an effect on ferroquine in vitro antimalarial activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In vitro susceptibility to ferroquine was measured for 80 isolates from Cambodia characterized for their molecular resistance profile to artemisinin, piperaquine and mefloquine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 80 isolates tested, the overall median (IQR) IC50 of ferroquine was 10.9\u2009nM (8.7\u201318.3). The ferroquine median (IQR) IC50 was 8.9\u2009nM (8.1\u201311.8) for Pfk13 WT parasites and was 12.9\u2009nM (9.5\u201320.0) for Pfk13 C580Y parasites with no amplification of Pfpm2 and Pfmdr1 genes. The median (IQR) IC50 of ferroquine for Pfk13 C580Y parasites with amplification of the Pfpm2 gene was 17.2\u2009nM (14.5\u201320.5) versus 9.1\u2009nM (7.9\u201310.7) for Pfk13 C580Y parasites with amplification of the Pfmdr1 gene.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ferroquine exerts promising efficacy against ACT-resistant isolates. Whereas Pfpm2 amplification was associated with the highest parasite tolerance to ferroquine, the susceptibility range observed was in accordance with those measured in ACT resistance-free areas. This enables consideration of ferroquine as a relevant therapeutic option against ACT-resistant malaria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkz340","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T07:25:50Z","timestamp":1563953150000},"page":"3240-3244","source":"Crossref","is-referenced-by-count":8,"title":["In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia"],"prefix":"10.1093","volume":"74","author":[{"given":"M\u00e9lissa","family":"Mairet-Khedim","sequence":"first","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Nardella","sequence":"additional","affiliation":[{"name":"Biology of Host\u2013Parasite Interactions Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimol","family":"Khim","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saorin","family":"Kim","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimol","family":"Kloeung","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopheakvatey","family":"Ke","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhayleang","family":"Kauy","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotha","family":"Eam","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanra","family":"Khean","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pellet","sequence":"additional","affiliation":[{"name":"Evotec ID, Marcy-l\u2019\u00c9toile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Leboulleux","sequence":"additional","affiliation":[{"name":"Evotec ID, Marcy-l\u2019\u00c9toile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithea","family":"Leang","sequence":"additional","affiliation":[{"name":"National Center for Malariology, Entomology and Malaria Control, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Ringwald","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Christophe","family":"Barale","sequence":"additional","affiliation":[{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"},{"name":"Unit\u00e9 de Microbiologie Structurale, Institut Pasteur, CNRS, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Leroy","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-4495","authenticated-orcid":false,"given":"Didier","family":"Menard","sequence":"additional","affiliation":[{"name":"Biology of Host\u2013Parasite Interactions Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Witkowski","sequence":"additional","affiliation":[{"name":"Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia"},{"name":"Malaria Translational Research Unit, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"2019101809594462500_dkz340-B1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMc1403007","article-title":"Dihydroartemisinin\u2013piperaquine failure in Cambodia","volume":"371","author":"Saunders","year":"2014","journal-title":"N Engl J Med"},{"key":"2019101809594462500_dkz340-B2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019101809594462500_dkz340-B3","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm970401y","article-title":"Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue","volume":"40","author":"Biot","year":"1997","journal-title":"J Med Chem"},{"key":"2019101809594462500_dkz340-B4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp0500061","article-title":"Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity","volume":"2","author":"Biot","year":"2005","journal-title":"Mol Pharm"},{"key":"2019101809594462500_dkz340-B5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4269\/ajtmh.2006.75.1178","article-title":"In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum","volume":"75","author":"Kreidenweiss","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2019101809594462500_dkz340-B6","doi-asserted-by":"crossref","first-page":"53.","DOI":"10.1186\/1475-2875-10-53","article-title":"Phase I randomized dose-ascending placebo-controlled trials of ferroquine\u2014a candidate anti-malarial drug\u2014in adults with asymptomatic Plasmodium falciparum infection","volume":"10","author":"Mombo-Ngoma","year":"2011","journal-title":"Malar J"},{"key":"2019101809594462500_dkz340-B7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4269\/ajtmh.16-0731","article-title":"Phase 2a, open-label, 4-escalating-dose, randomized multicenter study evaluating the safety and activity of ferroquine (SSR97193) plus artesunate, versus amodiaquine plus artesunate, in African adult men with uncomplicated Plasmodium falciparum malaria","volume":"97","author":"Walsh","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"2019101809594462500_dkz340-B8","doi-asserted-by":"crossref","first-page":"11.","DOI":"10.1186\/1475-2875-5-11","article-title":"Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure","volume":"5","author":"Daher","year":"2006","journal-title":"Malar J"},{"key":"2019101809594462500_dkz340-B9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2013","journal-title":"Nature"},{"key":"2019101809594462500_dkz340-B10","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","article-title":"The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand","volume":"43","author":"Price","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2019101809594462500_dkz340-B11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype\u2013genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019101809594462500_dkz340-B12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"2019101809594462500_dkz340-B13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/jac\/dkg161","article-title":"In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon","volume":"51","author":"Atteke","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2019101809594462500_dkz340-B14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-3156.2002.00848.x","article-title":"In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs","volume":"7","author":"Pradines","year":"2002","journal-title":"Trop Med Int Health"},{"key":"2019101809594462500_dkz340-B15","doi-asserted-by":"crossref","first-page":"81.","DOI":"10.1186\/1475-2875-6-81","article-title":"In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border","volume":"6","author":"Barends","year":"2007","journal-title":"Malar J"},{"key":"2019101809594462500_dkz340-B16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/mp800007x","article-title":"Investigation of the redox behavior of ferroquine, a new antimalarial","volume":"5","author":"Chavain","year":"2008","journal-title":"Mol Pharm"},{"key":"2019101809594462500_dkz340-B17","doi-asserted-by":"crossref","first-page":"1769.","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II\u2013III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat Commun"},{"key":"2019101809594462500_dkz340-B18","doi-asserted-by":"crossref","first-page":"469.","DOI":"10.1186\/s12936-016-1511-3","article-title":"A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study","volume":"15","author":"McCarthy","year":"2016","journal-title":"Malar J"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/11\/3240\/30192887\/dkz340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/11\/3240\/30192887\/dkz340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T10:09:50Z","timestamp":1571393390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/11\/3240\/5569492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":18,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,9,13]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz340","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,9,13]]}}}